Influenza Antiviral Drugs Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Influenza A, Influenza B, Influenza C); Treatment Type (Medication, Chemoprophylaxis, Others); Mechanism of Action (Cap- dependent endonuclease inhibitor, Nuraminidase Inhibitor, Matrix-2 Protein Inhibitor, Viral Uncoatings Inhibitors, Immunomodulators); Vaccine Type (Quadrivalent, Trivalent ,Others); Routes of Administration (Oral, Parenteral, Others); End Users (Hospitals, Clinics, Specialty Clinics, Others) and Geography
Report Code: TIPRE00015600 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Influenza Antiviral Drugs Market - By Type
1.3.2 Influenza Antiviral Drugs Market - By Treatment Type
1.3.3 Influenza Antiviral Drugs Market - By Mechanism of Action
1.3.4 Influenza Antiviral Drugs Market - By Vaccine Type
1.3.5 Influenza Antiviral Drugs Market - By Routes of Administration
1.3.6 Influenza Antiviral Drugs Market - By End Users
1.3.7 Influenza Antiviral Drugs Market - By Region
1.3.7.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. INFLUENZA ANTIVIRAL DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PORTER'S FIVE FORCES ANALYSIS
4.2.1 Bargaining Power of Buyers
4.2.1 Bargaining Power of Suppliers
4.2.1 Threat of Substitute
4.2.1 Threat of New Entrants
4.2.1 Competitive Rivalry
4.3. EXPERT OPINIONS
5. INFLUENZA ANTIVIRAL DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. INFLUENZA ANTIVIRAL DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. INFLUENZA ANTIVIRAL DRUGS - GLOBAL MARKET OVERVIEW
6.2. INFLUENZA ANTIVIRAL DRUGS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. INFLUENZA ANTIVIRAL DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. INFLUENZA A, INFLUENZA B, INFLUENZA C
7.3.1. Overview
7.3.2. Influenza A, Influenza B, Influenza C Market Forecast and Analysis
8. INFLUENZA ANTIVIRAL DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - TREATMENT TYPE
8.1. OVERVIEW
8.2. TREATMENT TYPE MARKET FORECASTS AND ANALYSIS
8.3. MEDICATION, CHEMOPROPHYLAXIS, OTHERS
8.3.1. Overview
8.3.2. Medication, Chemoprophylaxis, Others Market Forecast and Analysis
9. INFLUENZA ANTIVIRAL DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - MECHANISM OF ACTION
9.1. OVERVIEW
9.2. MECHANISM OF ACTION MARKET FORECASTS AND ANALYSIS
9.3. CAP- DEPENDENT ENDONUCLEASE INHIBITOR
9.3.1. Overview
9.3.2. Cap- dependent endonuclease inhibitor Market Forecast and Analysis
9.3.3. Daloxavir Market
9.3.3.1. Overview
9.3.3.2. Daloxavir Market Forecast and Analysis
9.4. NURAMINIDASE INHIBITOR
9.4.1. Overview
9.4.2. Nuraminidase Inhibitor Market Forecast and Analysis
9.4.3. Oseltamivir Market
9.4.3.1. Overview
9.4.3.2. Oseltamivir Market Forecast and Analysis
9.4.4. Zanamivir Market
9.4.4.1. Overview
9.4.4.2. Zanamivir Market Forecast and Analysis
9.4.5. Peramivir Market
9.4.5.1. Overview
9.4.5.2. Peramivir Market Forecast and Analysis
9.5. MATRIX-2 PROTEIN INHIBITOR
9.5.1. Overview
9.5.2. Matrix-2 Protein Inhibitor Market Forecast and Analysis
9.5.3. Amantadine Market
9.5.3.1. Overview
9.5.3.2. Amantadine Market Forecast and Analysis
9.6. VIRAL UNCOATINGS INHIBITORS
9.6.1. Overview
9.6.2. Viral Uncoatings Inhibitors Market Forecast and Analysis
9.6.3. Rimantadine Market
9.6.3.1. Overview
9.6.3.2. Rimantadine Market Forecast and Analysis
9.7. IMMUNOMODULATORS
9.7.1. Overview
9.7.2. Immunomodulators Market Forecast and Analysis
9.7.3. Inosine Market
9.7.3.1. Overview
9.7.3.2. Inosine Market Forecast and Analysis
10. INFLUENZA ANTIVIRAL DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - VACCINE TYPE
10.1. OVERVIEW
10.2. VACCINE TYPE MARKET FORECASTS AND ANALYSIS
10.3. QUADRIVALENT, TRIVALENT ,OTHERS
10.3.1. Overview
10.3.2. Quadrivalent, Trivalent ,Others Market Forecast and Analysis
11. INFLUENZA ANTIVIRAL DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - ROUTES OF ADMINISTRATION
11.1. OVERVIEW
11.2. ROUTES OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
11.3. ORAL, PARENTERAL, OTHERS
11.3.1. Overview
11.3.2. Oral, Parenteral, Others Market Forecast and Analysis
12. INFLUENZA ANTIVIRAL DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - END USERS
12.1. OVERVIEW
12.2. END USERS MARKET FORECASTS AND ANALYSIS
12.3. HOSPITALS, CLINICS, SPECIALTY CLINICS, OTHERS
12.3.1. Overview
12.3.2. Hospitals, Clinics, Specialty Clinics, Others Market Forecast and Analysis
13. INFLUENZA ANTIVIRAL DRUGS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
13.1. NORTH AMERICA
13.1.1 North America Influenza Antiviral Drugs Market Overview
13.1.2 North America Influenza Antiviral Drugs Market Forecasts and Analysis
13.1.3 North America Influenza Antiviral Drugs Market Forecasts and Analysis - By Type
13.1.4 North America Influenza Antiviral Drugs Market Forecasts and Analysis - By Treatment Type
13.1.5 North America Influenza Antiviral Drugs Market Forecasts and Analysis - By Mechanism of Action
13.1.6 North America Influenza Antiviral Drugs Market Forecasts and Analysis - By Vaccine Type
13.1.7 North America Influenza Antiviral Drugs Market Forecasts and Analysis - By Routes of Administration
13.1.8 North America Influenza Antiviral Drugs Market Forecasts and Analysis - By End Users
13.1.9 North America Influenza Antiviral Drugs Market Forecasts and Analysis - By Countries
13.1.9.1 United States Influenza Antiviral Drugs Market
13.1.9.1.1 United States Influenza Antiviral Drugs Market by Type
13.1.9.1.2 United States Influenza Antiviral Drugs Market by Treatment Type
13.1.9.1.3 United States Influenza Antiviral Drugs Market by Mechanism of Action
13.1.9.1.4 United States Influenza Antiviral Drugs Market by Vaccine Type
13.1.9.1.5 United States Influenza Antiviral Drugs Market by Routes of Administration
13.1.9.1.6 United States Influenza Antiviral Drugs Market by End Users
13.1.9.2 Canada Influenza Antiviral Drugs Market
13.1.9.2.1 Canada Influenza Antiviral Drugs Market by Type
13.1.9.2.2 Canada Influenza Antiviral Drugs Market by Treatment Type
13.1.9.2.3 Canada Influenza Antiviral Drugs Market by Mechanism of Action
13.1.9.2.4 Canada Influenza Antiviral Drugs Market by Vaccine Type
13.1.9.2.5 Canada Influenza Antiviral Drugs Market by Routes of Administration
13.1.9.2.6 Canada Influenza Antiviral Drugs Market by End Users
13.1.9.3 Mexico Influenza Antiviral Drugs Market
13.1.9.3.1 Mexico Influenza Antiviral Drugs Market by Type
13.1.9.3.2 Mexico Influenza Antiviral Drugs Market by Treatment Type
13.1.9.3.3 Mexico Influenza Antiviral Drugs Market by Mechanism of Action
13.1.9.3.4 Mexico Influenza Antiviral Drugs Market by Vaccine Type
13.1.9.3.5 Mexico Influenza Antiviral Drugs Market by Routes of Administration
13.1.9.3.6 Mexico Influenza Antiviral Drugs Market by End Users
13.2. EUROPE
13.2.1 Europe Influenza Antiviral Drugs Market Overview
13.2.2 Europe Influenza Antiviral Drugs Market Forecasts and Analysis
13.2.3 Europe Influenza Antiviral Drugs Market Forecasts and Analysis - By Type
13.2.4 Europe Influenza Antiviral Drugs Market Forecasts and Analysis - By Treatment Type
13.2.5 Europe Influenza Antiviral Drugs Market Forecasts and Analysis - By Mechanism of Action
13.2.6 Europe Influenza Antiviral Drugs Market Forecasts and Analysis - By Vaccine Type
13.2.7 Europe Influenza Antiviral Drugs Market Forecasts and Analysis - By Routes of Administration
13.2.8 Europe Influenza Antiviral Drugs Market Forecasts and Analysis - By End Users
13.2.9 Europe Influenza Antiviral Drugs Market Forecasts and Analysis - By Countries
13.2.9.1 Germany Influenza Antiviral Drugs Market
13.2.9.1.1 Germany Influenza Antiviral Drugs Market by Type
13.2.9.1.2 Germany Influenza Antiviral Drugs Market by Treatment Type
13.2.9.1.3 Germany Influenza Antiviral Drugs Market by Mechanism of Action
13.2.9.1.4 Germany Influenza Antiviral Drugs Market by Vaccine Type
13.2.9.1.5 Germany Influenza Antiviral Drugs Market by Routes of Administration
13.2.9.1.6 Germany Influenza Antiviral Drugs Market by End Users
13.2.9.2 France Influenza Antiviral Drugs Market
13.2.9.2.1 France Influenza Antiviral Drugs Market by Type
13.2.9.2.2 France Influenza Antiviral Drugs Market by Treatment Type
13.2.9.2.3 France Influenza Antiviral Drugs Market by Mechanism of Action
13.2.9.2.4 France Influenza Antiviral Drugs Market by Vaccine Type
13.2.9.2.5 France Influenza Antiviral Drugs Market by Routes of Administration
13.2.9.2.6 France Influenza Antiviral Drugs Market by End Users
13.2.9.3 Italy Influenza Antiviral Drugs Market
13.2.9.3.1 Italy Influenza Antiviral Drugs Market by Type
13.2.9.3.2 Italy Influenza Antiviral Drugs Market by Treatment Type
13.2.9.3.3 Italy Influenza Antiviral Drugs Market by Mechanism of Action
13.2.9.3.4 Italy Influenza Antiviral Drugs Market by Vaccine Type
13.2.9.3.5 Italy Influenza Antiviral Drugs Market by Routes of Administration
13.2.9.3.6 Italy Influenza Antiviral Drugs Market by End Users
13.2.9.4 Spain Influenza Antiviral Drugs Market
13.2.9.4.1 Spain Influenza Antiviral Drugs Market by Type
13.2.9.4.2 Spain Influenza Antiviral Drugs Market by Treatment Type
13.2.9.4.3 Spain Influenza Antiviral Drugs Market by Mechanism of Action
13.2.9.4.4 Spain Influenza Antiviral Drugs Market by Vaccine Type
13.2.9.4.5 Spain Influenza Antiviral Drugs Market by Routes of Administration
13.2.9.4.6 Spain Influenza Antiviral Drugs Market by End Users
13.2.9.5 United Kingdom Influenza Antiviral Drugs Market
13.2.9.5.1 United Kingdom Influenza Antiviral Drugs Market by Type
13.2.9.5.2 United Kingdom Influenza Antiviral Drugs Market by Treatment Type
13.2.9.5.3 United Kingdom Influenza Antiviral Drugs Market by Mechanism of Action
13.2.9.5.4 United Kingdom Influenza Antiviral Drugs Market by Vaccine Type
13.2.9.5.5 United Kingdom Influenza Antiviral Drugs Market by Routes of Administration
13.2.9.5.6 United Kingdom Influenza Antiviral Drugs Market by End Users
13.2.9.6 Rest of Europe Influenza Antiviral Drugs Market
13.2.9.6.1 Rest of Europe Influenza Antiviral Drugs Market by Type
13.2.9.6.2 Rest of Europe Influenza Antiviral Drugs Market by Treatment Type
13.2.9.6.3 Rest of Europe Influenza Antiviral Drugs Market by Mechanism of Action
13.2.9.6.4 Rest of Europe Influenza Antiviral Drugs Market by Vaccine Type
13.2.9.6.5 Rest of Europe Influenza Antiviral Drugs Market by Routes of Administration
13.2.9.6.6 Rest of Europe Influenza Antiviral Drugs Market by End Users
13.3. ASIA-PACIFIC
13.3.1 Asia-Pacific Influenza Antiviral Drugs Market Overview
13.3.2 Asia-Pacific Influenza Antiviral Drugs Market Forecasts and Analysis
13.3.3 Asia-Pacific Influenza Antiviral Drugs Market Forecasts and Analysis - By Type
13.3.4 Asia-Pacific Influenza Antiviral Drugs Market Forecasts and Analysis - By Treatment Type
13.3.5 Asia-Pacific Influenza Antiviral Drugs Market Forecasts and Analysis - By Mechanism of Action
13.3.6 Asia-Pacific Influenza Antiviral Drugs Market Forecasts and Analysis - By Vaccine Type
13.3.7 Asia-Pacific Influenza Antiviral Drugs Market Forecasts and Analysis - By Routes of Administration
13.3.8 Asia-Pacific Influenza Antiviral Drugs Market Forecasts and Analysis - By End Users
13.3.9 Asia-Pacific Influenza Antiviral Drugs Market Forecasts and Analysis - By Countries
13.3.9.1 Australia Influenza Antiviral Drugs Market
13.3.9.1.1 Australia Influenza Antiviral Drugs Market by Type
13.3.9.1.2 Australia Influenza Antiviral Drugs Market by Treatment Type
13.3.9.1.3 Australia Influenza Antiviral Drugs Market by Mechanism of Action
13.3.9.1.4 Australia Influenza Antiviral Drugs Market by Vaccine Type
13.3.9.1.5 Australia Influenza Antiviral Drugs Market by Routes of Administration
13.3.9.1.6 Australia Influenza Antiviral Drugs Market by End Users
13.3.9.2 China Influenza Antiviral Drugs Market
13.3.9.2.1 China Influenza Antiviral Drugs Market by Type
13.3.9.2.2 China Influenza Antiviral Drugs Market by Treatment Type
13.3.9.2.3 China Influenza Antiviral Drugs Market by Mechanism of Action
13.3.9.2.4 China Influenza Antiviral Drugs Market by Vaccine Type
13.3.9.2.5 China Influenza Antiviral Drugs Market by Routes of Administration
13.3.9.2.6 China Influenza Antiviral Drugs Market by End Users
13.3.9.3 India Influenza Antiviral Drugs Market
13.3.9.3.1 India Influenza Antiviral Drugs Market by Type
13.3.9.3.2 India Influenza Antiviral Drugs Market by Treatment Type
13.3.9.3.3 India Influenza Antiviral Drugs Market by Mechanism of Action
13.3.9.3.4 India Influenza Antiviral Drugs Market by Vaccine Type
13.3.9.3.5 India Influenza Antiviral Drugs Market by Routes of Administration
13.3.9.3.6 India Influenza Antiviral Drugs Market by End Users
13.3.9.4 Japan Influenza Antiviral Drugs Market
13.3.9.4.1 Japan Influenza Antiviral Drugs Market by Type
13.3.9.4.2 Japan Influenza Antiviral Drugs Market by Treatment Type
13.3.9.4.3 Japan Influenza Antiviral Drugs Market by Mechanism of Action
13.3.9.4.4 Japan Influenza Antiviral Drugs Market by Vaccine Type
13.3.9.4.5 Japan Influenza Antiviral Drugs Market by Routes of Administration
13.3.9.4.6 Japan Influenza Antiviral Drugs Market by End Users
13.3.9.5 South Korea Influenza Antiviral Drugs Market
13.3.9.5.1 South Korea Influenza Antiviral Drugs Market by Type
13.3.9.5.2 South Korea Influenza Antiviral Drugs Market by Treatment Type
13.3.9.5.3 South Korea Influenza Antiviral Drugs Market by Mechanism of Action
13.3.9.5.4 South Korea Influenza Antiviral Drugs Market by Vaccine Type
13.3.9.5.5 South Korea Influenza Antiviral Drugs Market by Routes of Administration
13.3.9.5.6 South Korea Influenza Antiviral Drugs Market by End Users
13.3.9.6 Rest of Asia-Pacific Influenza Antiviral Drugs Market
13.3.9.6.1 Rest of Asia-Pacific Influenza Antiviral Drugs Market by Type
13.3.9.6.2 Rest of Asia-Pacific Influenza Antiviral Drugs Market by Treatment Type
13.3.9.6.3 Rest of Asia-Pacific Influenza Antiviral Drugs Market by Mechanism of Action
13.3.9.6.4 Rest of Asia-Pacific Influenza Antiviral Drugs Market by Vaccine Type
13.3.9.6.5 Rest of Asia-Pacific Influenza Antiviral Drugs Market by Routes of Administration
13.3.9.6.6 Rest of Asia-Pacific Influenza Antiviral Drugs Market by End Users
13.4. MIDDLE EAST AND AFRICA
13.4.1 Middle East and Africa Influenza Antiviral Drugs Market Overview
13.4.2 Middle East and Africa Influenza Antiviral Drugs Market Forecasts and Analysis
13.4.3 Middle East and Africa Influenza Antiviral Drugs Market Forecasts and Analysis - By Type
13.4.4 Middle East and Africa Influenza Antiviral Drugs Market Forecasts and Analysis - By Treatment Type
13.4.5 Middle East and Africa Influenza Antiviral Drugs Market Forecasts and Analysis - By Mechanism of Action
13.4.6 Middle East and Africa Influenza Antiviral Drugs Market Forecasts and Analysis - By Vaccine Type
13.4.7 Middle East and Africa Influenza Antiviral Drugs Market Forecasts and Analysis - By Routes of Administration
13.4.8 Middle East and Africa Influenza Antiviral Drugs Market Forecasts and Analysis - By End Users
13.4.9 Middle East and Africa Influenza Antiviral Drugs Market Forecasts and Analysis - By Countries
13.4.9.1 South Africa Influenza Antiviral Drugs Market
13.4.9.1.1 South Africa Influenza Antiviral Drugs Market by Type
13.4.9.1.2 South Africa Influenza Antiviral Drugs Market by Treatment Type
13.4.9.1.3 South Africa Influenza Antiviral Drugs Market by Mechanism of Action
13.4.9.1.4 South Africa Influenza Antiviral Drugs Market by Vaccine Type
13.4.9.1.5 South Africa Influenza Antiviral Drugs Market by Routes of Administration
13.4.9.1.6 South Africa Influenza Antiviral Drugs Market by End Users
13.4.9.2 Saudi Arabia Influenza Antiviral Drugs Market
13.4.9.2.1 Saudi Arabia Influenza Antiviral Drugs Market by Type
13.4.9.2.2 Saudi Arabia Influenza Antiviral Drugs Market by Treatment Type
13.4.9.2.3 Saudi Arabia Influenza Antiviral Drugs Market by Mechanism of Action
13.4.9.2.4 Saudi Arabia Influenza Antiviral Drugs Market by Vaccine Type
13.4.9.2.5 Saudi Arabia Influenza Antiviral Drugs Market by Routes of Administration
13.4.9.2.6 Saudi Arabia Influenza Antiviral Drugs Market by End Users
13.4.9.3 U.A.E Influenza Antiviral Drugs Market
13.4.9.3.1 U.A.E Influenza Antiviral Drugs Market by Type
13.4.9.3.2 U.A.E Influenza Antiviral Drugs Market by Treatment Type
13.4.9.3.3 U.A.E Influenza Antiviral Drugs Market by Mechanism of Action
13.4.9.3.4 U.A.E Influenza Antiviral Drugs Market by Vaccine Type
13.4.9.3.5 U.A.E Influenza Antiviral Drugs Market by Routes of Administration
13.4.9.3.6 U.A.E Influenza Antiviral Drugs Market by End Users
13.4.9.4 Rest of Middle East and Africa Influenza Antiviral Drugs Market
13.4.9.4.1 Rest of Middle East and Africa Influenza Antiviral Drugs Market by Type
13.4.9.4.2 Rest of Middle East and Africa Influenza Antiviral Drugs Market by Treatment Type
13.4.9.4.3 Rest of Middle East and Africa Influenza Antiviral Drugs Market by Mechanism of Action
13.4.9.4.4 Rest of Middle East and Africa Influenza Antiviral Drugs Market by Vaccine Type
13.4.9.4.5 Rest of Middle East and Africa Influenza Antiviral Drugs Market by Routes of Administration
13.4.9.4.6 Rest of Middle East and Africa Influenza Antiviral Drugs Market by End Users
13.5. SOUTH AND CENTRAL AMERICA
13.5.1 South and Central America Influenza Antiviral Drugs Market Overview
13.5.2 South and Central America Influenza Antiviral Drugs Market Forecasts and Analysis
13.5.3 South and Central America Influenza Antiviral Drugs Market Forecasts and Analysis - By Type
13.5.4 South and Central America Influenza Antiviral Drugs Market Forecasts and Analysis - By Treatment Type
13.5.5 South and Central America Influenza Antiviral Drugs Market Forecasts and Analysis - By Mechanism of Action
13.5.6 South and Central America Influenza Antiviral Drugs Market Forecasts and Analysis - By Vaccine Type
13.5.7 South and Central America Influenza Antiviral Drugs Market Forecasts and Analysis - By Routes of Administration
13.5.8 South and Central America Influenza Antiviral Drugs Market Forecasts and Analysis - By End Users
13.5.9 South and Central America Influenza Antiviral Drugs Market Forecasts and Analysis - By Countries
13.5.9.1 Brazil Influenza Antiviral Drugs Market
13.5.9.1.1 Brazil Influenza Antiviral Drugs Market by Type
13.5.9.1.2 Brazil Influenza Antiviral Drugs Market by Treatment Type
13.5.9.1.3 Brazil Influenza Antiviral Drugs Market by Mechanism of Action
13.5.9.1.4 Brazil Influenza Antiviral Drugs Market by Vaccine Type
13.5.9.1.5 Brazil Influenza Antiviral Drugs Market by Routes of Administration
13.5.9.1.6 Brazil Influenza Antiviral Drugs Market by End Users
13.5.9.2 Argentina Influenza Antiviral Drugs Market
13.5.9.2.1 Argentina Influenza Antiviral Drugs Market by Type
13.5.9.2.2 Argentina Influenza Antiviral Drugs Market by Treatment Type
13.5.9.2.3 Argentina Influenza Antiviral Drugs Market by Mechanism of Action
13.5.9.2.4 Argentina Influenza Antiviral Drugs Market by Vaccine Type
13.5.9.2.5 Argentina Influenza Antiviral Drugs Market by Routes of Administration
13.5.9.2.6 Argentina Influenza Antiviral Drugs Market by End Users
13.5.9.3 Rest of South and Central America Influenza Antiviral Drugs Market
13.5.9.3.1 Rest of South and Central America Influenza Antiviral Drugs Market by Type
13.5.9.3.2 Rest of South and Central America Influenza Antiviral Drugs Market by Treatment Type
13.5.9.3.3 Rest of South and Central America Influenza Antiviral Drugs Market by Mechanism of Action
13.5.9.3.4 Rest of South and Central America Influenza Antiviral Drugs Market by Vaccine Type
13.5.9.3.5 Rest of South and Central America Influenza Antiviral Drugs Market by Routes of Administration
13.5.9.3.6 Rest of South and Central America Influenza Antiviral Drugs Market by End Users
14. INDUSTRY LANDSCAPE
14.1. MERGERS AND ACQUISITIONS
14.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
14.3. NEW PRODUCT LAUNCHES
14.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
15. INFLUENZA ANTIVIRAL DRUGS MARKET, KEY COMPANY PROFILES
15.1. SUN PHARMACEUTICAL INDUSTRIES LTD
15.1.1. Key Facts
15.1.2. Business Description
15.1.3. Products and Services
15.1.4. Financial Overview
15.1.5. SWOT Analysis
15.1.6. Key Developments
15.2. ADMA BIOLOGICS, INC
15.2.1. Key Facts
15.2.2. Business Description
15.2.3. Products and Services
15.2.4. Financial Overview
15.2.5. SWOT Analysis
15.2.6. Key Developments
15.3. SHIONOGI INC
15.3.1. Key Facts
15.3.2. Business Description
15.3.3. Products and Services
15.3.4. Financial Overview
15.3.5. SWOT Analysis
15.3.6. Key Developments
15.4. F. HOFFMANN-LA ROCHE LTD
15.4.1. Key Facts
15.4.2. Business Description
15.4.3. Products and Services
15.4.4. Financial Overview
15.4.5. SWOT Analysis
15.4.6. Key Developments
15.5. CIPLA INC
15.5.1. Key Facts
15.5.2. Business Description
15.5.3. Products and Services
15.5.4. Financial Overview
15.5.5. SWOT Analysis
15.5.6. Key Developments
15.6. GLAXOSMITHKLINE PLC
15.6.1. Key Facts
15.6.2. Business Description
15.6.3. Products and Services
15.6.4. Financial Overview
15.6.5. SWOT Analysis
15.6.6. Key Developments
15.7. TEVA PHARMACEUTICAL INDUSTRIES LTD
15.7.1. Key Facts
15.7.2. Business Description
15.7.3. Products and Services
15.7.4. Financial Overview
15.7.5. SWOT Analysis
15.7.6. Key Developments
15.8. NOVARTIS AG
15.8.1. Key Facts
15.8.2. Business Description
15.8.3. Products and Services
15.8.4. Financial Overview
15.8.5. SWOT Analysis
15.8.6. Key Developments
15.9. SANOFI
15.9.1. Key Facts
15.9.2. Business Description
15.9.3. Products and Services
15.9.4. Financial Overview
15.9.5. SWOT Analysis
15.9.6. Key Developments
15.10. ASTRAZENECA
15.10.1. Key Facts
15.10.2. Business Description
15.10.3. Products and Services
15.10.4. Financial Overview
15.10.5. SWOT Analysis
15.10.6. Key Developments
16. APPENDIX
16.1. ABOUT THE INSIGHT PARTNERS
16.2. GLOSSARY OF TERMS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Influenza Antiviral Drugs Market - By Type
1.3.2 Influenza Antiviral Drugs Market - By Treatment Type
1.3.3 Influenza Antiviral Drugs Market - By Mechanism of Action
1.3.4 Influenza Antiviral Drugs Market - By Vaccine Type
1.3.5 Influenza Antiviral Drugs Market - By Routes of Administration
1.3.6 Influenza Antiviral Drugs Market - By End Users
1.3.7 Influenza Antiviral Drugs Market - By Region
1.3.7.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. INFLUENZA ANTIVIRAL DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PORTER'S FIVE FORCES ANALYSIS
4.2.1 Bargaining Power of Buyers
4.2.1 Bargaining Power of Suppliers
4.2.1 Threat of Substitute
4.2.1 Threat of New Entrants
4.2.1 Competitive Rivalry
4.3. EXPERT OPINIONS
5. INFLUENZA ANTIVIRAL DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. INFLUENZA ANTIVIRAL DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. INFLUENZA ANTIVIRAL DRUGS - GLOBAL MARKET OVERVIEW
6.2. INFLUENZA ANTIVIRAL DRUGS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. INFLUENZA ANTIVIRAL DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. INFLUENZA A, INFLUENZA B, INFLUENZA C
7.3.1. Overview
7.3.2. Influenza A, Influenza B, Influenza C Market Forecast and Analysis
8. INFLUENZA ANTIVIRAL DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - TREATMENT TYPE
8.1. OVERVIEW
8.2. TREATMENT TYPE MARKET FORECASTS AND ANALYSIS
8.3. MEDICATION, CHEMOPROPHYLAXIS, OTHERS
8.3.1. Overview
8.3.2. Medication, Chemoprophylaxis, Others Market Forecast and Analysis
9. INFLUENZA ANTIVIRAL DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - MECHANISM OF ACTION
9.1. OVERVIEW
9.2. MECHANISM OF ACTION MARKET FORECASTS AND ANALYSIS
9.3. CAP- DEPENDENT ENDONUCLEASE INHIBITOR
9.3.1. Overview
9.3.2. Cap- dependent endonuclease inhibitor Market Forecast and Analysis
9.3.3. Daloxavir Market
9.3.3.1. Overview
9.3.3.2. Daloxavir Market Forecast and Analysis
9.4. NURAMINIDASE INHIBITOR
9.4.1. Overview
9.4.2. Nuraminidase Inhibitor Market Forecast and Analysis
9.4.3. Oseltamivir Market
9.4.3.1. Overview
9.4.3.2. Oseltamivir Market Forecast and Analysis
9.4.4. Zanamivir Market
9.4.4.1. Overview
9.4.4.2. Zanamivir Market Forecast and Analysis
9.4.5. Peramivir Market
9.4.5.1. Overview
9.4.5.2. Peramivir Market Forecast and Analysis
9.5. MATRIX-2 PROTEIN INHIBITOR
9.5.1. Overview
9.5.2. Matrix-2 Protein Inhibitor Market Forecast and Analysis
9.5.3. Amantadine Market
9.5.3.1. Overview
9.5.3.2. Amantadine Market Forecast and Analysis
9.6. VIRAL UNCOATINGS INHIBITORS
9.6.1. Overview
9.6.2. Viral Uncoatings Inhibitors Market Forecast and Analysis
9.6.3. Rimantadine Market
9.6.3.1. Overview
9.6.3.2. Rimantadine Market Forecast and Analysis
9.7. IMMUNOMODULATORS
9.7.1. Overview
9.7.2. Immunomodulators Market Forecast and Analysis
9.7.3. Inosine Market
9.7.3.1. Overview
9.7.3.2. Inosine Market Forecast and Analysis
10. INFLUENZA ANTIVIRAL DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - VACCINE TYPE
10.1. OVERVIEW
10.2. VACCINE TYPE MARKET FORECASTS AND ANALYSIS
10.3. QUADRIVALENT, TRIVALENT ,OTHERS
10.3.1. Overview
10.3.2. Quadrivalent, Trivalent ,Others Market Forecast and Analysis
11. INFLUENZA ANTIVIRAL DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - ROUTES OF ADMINISTRATION
11.1. OVERVIEW
11.2. ROUTES OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
11.3. ORAL, PARENTERAL, OTHERS
11.3.1. Overview
11.3.2. Oral, Parenteral, Others Market Forecast and Analysis
12. INFLUENZA ANTIVIRAL DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - END USERS
12.1. OVERVIEW
12.2. END USERS MARKET FORECASTS AND ANALYSIS
12.3. HOSPITALS, CLINICS, SPECIALTY CLINICS, OTHERS
12.3.1. Overview
12.3.2. Hospitals, Clinics, Specialty Clinics, Others Market Forecast and Analysis
13. INFLUENZA ANTIVIRAL DRUGS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
13.1. NORTH AMERICA
13.1.1 North America Influenza Antiviral Drugs Market Overview
13.1.2 North America Influenza Antiviral Drugs Market Forecasts and Analysis
13.1.3 North America Influenza Antiviral Drugs Market Forecasts and Analysis - By Type
13.1.4 North America Influenza Antiviral Drugs Market Forecasts and Analysis - By Treatment Type
13.1.5 North America Influenza Antiviral Drugs Market Forecasts and Analysis - By Mechanism of Action
13.1.6 North America Influenza Antiviral Drugs Market Forecasts and Analysis - By Vaccine Type
13.1.7 North America Influenza Antiviral Drugs Market Forecasts and Analysis - By Routes of Administration
13.1.8 North America Influenza Antiviral Drugs Market Forecasts and Analysis - By End Users
13.1.9 North America Influenza Antiviral Drugs Market Forecasts and Analysis - By Countries
13.1.9.1 United States Influenza Antiviral Drugs Market
13.1.9.1.1 United States Influenza Antiviral Drugs Market by Type
13.1.9.1.2 United States Influenza Antiviral Drugs Market by Treatment Type
13.1.9.1.3 United States Influenza Antiviral Drugs Market by Mechanism of Action
13.1.9.1.4 United States Influenza Antiviral Drugs Market by Vaccine Type
13.1.9.1.5 United States Influenza Antiviral Drugs Market by Routes of Administration
13.1.9.1.6 United States Influenza Antiviral Drugs Market by End Users
13.1.9.2 Canada Influenza Antiviral Drugs Market
13.1.9.2.1 Canada Influenza Antiviral Drugs Market by Type
13.1.9.2.2 Canada Influenza Antiviral Drugs Market by Treatment Type
13.1.9.2.3 Canada Influenza Antiviral Drugs Market by Mechanism of Action
13.1.9.2.4 Canada Influenza Antiviral Drugs Market by Vaccine Type
13.1.9.2.5 Canada Influenza Antiviral Drugs Market by Routes of Administration
13.1.9.2.6 Canada Influenza Antiviral Drugs Market by End Users
13.1.9.3 Mexico Influenza Antiviral Drugs Market
13.1.9.3.1 Mexico Influenza Antiviral Drugs Market by Type
13.1.9.3.2 Mexico Influenza Antiviral Drugs Market by Treatment Type
13.1.9.3.3 Mexico Influenza Antiviral Drugs Market by Mechanism of Action
13.1.9.3.4 Mexico Influenza Antiviral Drugs Market by Vaccine Type
13.1.9.3.5 Mexico Influenza Antiviral Drugs Market by Routes of Administration
13.1.9.3.6 Mexico Influenza Antiviral Drugs Market by End Users
13.2. EUROPE
13.2.1 Europe Influenza Antiviral Drugs Market Overview
13.2.2 Europe Influenza Antiviral Drugs Market Forecasts and Analysis
13.2.3 Europe Influenza Antiviral Drugs Market Forecasts and Analysis - By Type
13.2.4 Europe Influenza Antiviral Drugs Market Forecasts and Analysis - By Treatment Type
13.2.5 Europe Influenza Antiviral Drugs Market Forecasts and Analysis - By Mechanism of Action
13.2.6 Europe Influenza Antiviral Drugs Market Forecasts and Analysis - By Vaccine Type
13.2.7 Europe Influenza Antiviral Drugs Market Forecasts and Analysis - By Routes of Administration
13.2.8 Europe Influenza Antiviral Drugs Market Forecasts and Analysis - By End Users
13.2.9 Europe Influenza Antiviral Drugs Market Forecasts and Analysis - By Countries
13.2.9.1 Germany Influenza Antiviral Drugs Market
13.2.9.1.1 Germany Influenza Antiviral Drugs Market by Type
13.2.9.1.2 Germany Influenza Antiviral Drugs Market by Treatment Type
13.2.9.1.3 Germany Influenza Antiviral Drugs Market by Mechanism of Action
13.2.9.1.4 Germany Influenza Antiviral Drugs Market by Vaccine Type
13.2.9.1.5 Germany Influenza Antiviral Drugs Market by Routes of Administration
13.2.9.1.6 Germany Influenza Antiviral Drugs Market by End Users
13.2.9.2 France Influenza Antiviral Drugs Market
13.2.9.2.1 France Influenza Antiviral Drugs Market by Type
13.2.9.2.2 France Influenza Antiviral Drugs Market by Treatment Type
13.2.9.2.3 France Influenza Antiviral Drugs Market by Mechanism of Action
13.2.9.2.4 France Influenza Antiviral Drugs Market by Vaccine Type
13.2.9.2.5 France Influenza Antiviral Drugs Market by Routes of Administration
13.2.9.2.6 France Influenza Antiviral Drugs Market by End Users
13.2.9.3 Italy Influenza Antiviral Drugs Market
13.2.9.3.1 Italy Influenza Antiviral Drugs Market by Type
13.2.9.3.2 Italy Influenza Antiviral Drugs Market by Treatment Type
13.2.9.3.3 Italy Influenza Antiviral Drugs Market by Mechanism of Action
13.2.9.3.4 Italy Influenza Antiviral Drugs Market by Vaccine Type
13.2.9.3.5 Italy Influenza Antiviral Drugs Market by Routes of Administration
13.2.9.3.6 Italy Influenza Antiviral Drugs Market by End Users
13.2.9.4 Spain Influenza Antiviral Drugs Market
13.2.9.4.1 Spain Influenza Antiviral Drugs Market by Type
13.2.9.4.2 Spain Influenza Antiviral Drugs Market by Treatment Type
13.2.9.4.3 Spain Influenza Antiviral Drugs Market by Mechanism of Action
13.2.9.4.4 Spain Influenza Antiviral Drugs Market by Vaccine Type
13.2.9.4.5 Spain Influenza Antiviral Drugs Market by Routes of Administration
13.2.9.4.6 Spain Influenza Antiviral Drugs Market by End Users
13.2.9.5 United Kingdom Influenza Antiviral Drugs Market
13.2.9.5.1 United Kingdom Influenza Antiviral Drugs Market by Type
13.2.9.5.2 United Kingdom Influenza Antiviral Drugs Market by Treatment Type
13.2.9.5.3 United Kingdom Influenza Antiviral Drugs Market by Mechanism of Action
13.2.9.5.4 United Kingdom Influenza Antiviral Drugs Market by Vaccine Type
13.2.9.5.5 United Kingdom Influenza Antiviral Drugs Market by Routes of Administration
13.2.9.5.6 United Kingdom Influenza Antiviral Drugs Market by End Users
13.2.9.6 Rest of Europe Influenza Antiviral Drugs Market
13.2.9.6.1 Rest of Europe Influenza Antiviral Drugs Market by Type
13.2.9.6.2 Rest of Europe Influenza Antiviral Drugs Market by Treatment Type
13.2.9.6.3 Rest of Europe Influenza Antiviral Drugs Market by Mechanism of Action
13.2.9.6.4 Rest of Europe Influenza Antiviral Drugs Market by Vaccine Type
13.2.9.6.5 Rest of Europe Influenza Antiviral Drugs Market by Routes of Administration
13.2.9.6.6 Rest of Europe Influenza Antiviral Drugs Market by End Users
13.3. ASIA-PACIFIC
13.3.1 Asia-Pacific Influenza Antiviral Drugs Market Overview
13.3.2 Asia-Pacific Influenza Antiviral Drugs Market Forecasts and Analysis
13.3.3 Asia-Pacific Influenza Antiviral Drugs Market Forecasts and Analysis - By Type
13.3.4 Asia-Pacific Influenza Antiviral Drugs Market Forecasts and Analysis - By Treatment Type
13.3.5 Asia-Pacific Influenza Antiviral Drugs Market Forecasts and Analysis - By Mechanism of Action
13.3.6 Asia-Pacific Influenza Antiviral Drugs Market Forecasts and Analysis - By Vaccine Type
13.3.7 Asia-Pacific Influenza Antiviral Drugs Market Forecasts and Analysis - By Routes of Administration
13.3.8 Asia-Pacific Influenza Antiviral Drugs Market Forecasts and Analysis - By End Users
13.3.9 Asia-Pacific Influenza Antiviral Drugs Market Forecasts and Analysis - By Countries
13.3.9.1 Australia Influenza Antiviral Drugs Market
13.3.9.1.1 Australia Influenza Antiviral Drugs Market by Type
13.3.9.1.2 Australia Influenza Antiviral Drugs Market by Treatment Type
13.3.9.1.3 Australia Influenza Antiviral Drugs Market by Mechanism of Action
13.3.9.1.4 Australia Influenza Antiviral Drugs Market by Vaccine Type
13.3.9.1.5 Australia Influenza Antiviral Drugs Market by Routes of Administration
13.3.9.1.6 Australia Influenza Antiviral Drugs Market by End Users
13.3.9.2 China Influenza Antiviral Drugs Market
13.3.9.2.1 China Influenza Antiviral Drugs Market by Type
13.3.9.2.2 China Influenza Antiviral Drugs Market by Treatment Type
13.3.9.2.3 China Influenza Antiviral Drugs Market by Mechanism of Action
13.3.9.2.4 China Influenza Antiviral Drugs Market by Vaccine Type
13.3.9.2.5 China Influenza Antiviral Drugs Market by Routes of Administration
13.3.9.2.6 China Influenza Antiviral Drugs Market by End Users
13.3.9.3 India Influenza Antiviral Drugs Market
13.3.9.3.1 India Influenza Antiviral Drugs Market by Type
13.3.9.3.2 India Influenza Antiviral Drugs Market by Treatment Type
13.3.9.3.3 India Influenza Antiviral Drugs Market by Mechanism of Action
13.3.9.3.4 India Influenza Antiviral Drugs Market by Vaccine Type
13.3.9.3.5 India Influenza Antiviral Drugs Market by Routes of Administration
13.3.9.3.6 India Influenza Antiviral Drugs Market by End Users
13.3.9.4 Japan Influenza Antiviral Drugs Market
13.3.9.4.1 Japan Influenza Antiviral Drugs Market by Type
13.3.9.4.2 Japan Influenza Antiviral Drugs Market by Treatment Type
13.3.9.4.3 Japan Influenza Antiviral Drugs Market by Mechanism of Action
13.3.9.4.4 Japan Influenza Antiviral Drugs Market by Vaccine Type
13.3.9.4.5 Japan Influenza Antiviral Drugs Market by Routes of Administration
13.3.9.4.6 Japan Influenza Antiviral Drugs Market by End Users
13.3.9.5 South Korea Influenza Antiviral Drugs Market
13.3.9.5.1 South Korea Influenza Antiviral Drugs Market by Type
13.3.9.5.2 South Korea Influenza Antiviral Drugs Market by Treatment Type
13.3.9.5.3 South Korea Influenza Antiviral Drugs Market by Mechanism of Action
13.3.9.5.4 South Korea Influenza Antiviral Drugs Market by Vaccine Type
13.3.9.5.5 South Korea Influenza Antiviral Drugs Market by Routes of Administration
13.3.9.5.6 South Korea Influenza Antiviral Drugs Market by End Users
13.3.9.6 Rest of Asia-Pacific Influenza Antiviral Drugs Market
13.3.9.6.1 Rest of Asia-Pacific Influenza Antiviral Drugs Market by Type
13.3.9.6.2 Rest of Asia-Pacific Influenza Antiviral Drugs Market by Treatment Type
13.3.9.6.3 Rest of Asia-Pacific Influenza Antiviral Drugs Market by Mechanism of Action
13.3.9.6.4 Rest of Asia-Pacific Influenza Antiviral Drugs Market by Vaccine Type
13.3.9.6.5 Rest of Asia-Pacific Influenza Antiviral Drugs Market by Routes of Administration
13.3.9.6.6 Rest of Asia-Pacific Influenza Antiviral Drugs Market by End Users
13.4. MIDDLE EAST AND AFRICA
13.4.1 Middle East and Africa Influenza Antiviral Drugs Market Overview
13.4.2 Middle East and Africa Influenza Antiviral Drugs Market Forecasts and Analysis
13.4.3 Middle East and Africa Influenza Antiviral Drugs Market Forecasts and Analysis - By Type
13.4.4 Middle East and Africa Influenza Antiviral Drugs Market Forecasts and Analysis - By Treatment Type
13.4.5 Middle East and Africa Influenza Antiviral Drugs Market Forecasts and Analysis - By Mechanism of Action
13.4.6 Middle East and Africa Influenza Antiviral Drugs Market Forecasts and Analysis - By Vaccine Type
13.4.7 Middle East and Africa Influenza Antiviral Drugs Market Forecasts and Analysis - By Routes of Administration
13.4.8 Middle East and Africa Influenza Antiviral Drugs Market Forecasts and Analysis - By End Users
13.4.9 Middle East and Africa Influenza Antiviral Drugs Market Forecasts and Analysis - By Countries
13.4.9.1 South Africa Influenza Antiviral Drugs Market
13.4.9.1.1 South Africa Influenza Antiviral Drugs Market by Type
13.4.9.1.2 South Africa Influenza Antiviral Drugs Market by Treatment Type
13.4.9.1.3 South Africa Influenza Antiviral Drugs Market by Mechanism of Action
13.4.9.1.4 South Africa Influenza Antiviral Drugs Market by Vaccine Type
13.4.9.1.5 South Africa Influenza Antiviral Drugs Market by Routes of Administration
13.4.9.1.6 South Africa Influenza Antiviral Drugs Market by End Users
13.4.9.2 Saudi Arabia Influenza Antiviral Drugs Market
13.4.9.2.1 Saudi Arabia Influenza Antiviral Drugs Market by Type
13.4.9.2.2 Saudi Arabia Influenza Antiviral Drugs Market by Treatment Type
13.4.9.2.3 Saudi Arabia Influenza Antiviral Drugs Market by Mechanism of Action
13.4.9.2.4 Saudi Arabia Influenza Antiviral Drugs Market by Vaccine Type
13.4.9.2.5 Saudi Arabia Influenza Antiviral Drugs Market by Routes of Administration
13.4.9.2.6 Saudi Arabia Influenza Antiviral Drugs Market by End Users
13.4.9.3 U.A.E Influenza Antiviral Drugs Market
13.4.9.3.1 U.A.E Influenza Antiviral Drugs Market by Type
13.4.9.3.2 U.A.E Influenza Antiviral Drugs Market by Treatment Type
13.4.9.3.3 U.A.E Influenza Antiviral Drugs Market by Mechanism of Action
13.4.9.3.4 U.A.E Influenza Antiviral Drugs Market by Vaccine Type
13.4.9.3.5 U.A.E Influenza Antiviral Drugs Market by Routes of Administration
13.4.9.3.6 U.A.E Influenza Antiviral Drugs Market by End Users
13.4.9.4 Rest of Middle East and Africa Influenza Antiviral Drugs Market
13.4.9.4.1 Rest of Middle East and Africa Influenza Antiviral Drugs Market by Type
13.4.9.4.2 Rest of Middle East and Africa Influenza Antiviral Drugs Market by Treatment Type
13.4.9.4.3 Rest of Middle East and Africa Influenza Antiviral Drugs Market by Mechanism of Action
13.4.9.4.4 Rest of Middle East and Africa Influenza Antiviral Drugs Market by Vaccine Type
13.4.9.4.5 Rest of Middle East and Africa Influenza Antiviral Drugs Market by Routes of Administration
13.4.9.4.6 Rest of Middle East and Africa Influenza Antiviral Drugs Market by End Users
13.5. SOUTH AND CENTRAL AMERICA
13.5.1 South and Central America Influenza Antiviral Drugs Market Overview
13.5.2 South and Central America Influenza Antiviral Drugs Market Forecasts and Analysis
13.5.3 South and Central America Influenza Antiviral Drugs Market Forecasts and Analysis - By Type
13.5.4 South and Central America Influenza Antiviral Drugs Market Forecasts and Analysis - By Treatment Type
13.5.5 South and Central America Influenza Antiviral Drugs Market Forecasts and Analysis - By Mechanism of Action
13.5.6 South and Central America Influenza Antiviral Drugs Market Forecasts and Analysis - By Vaccine Type
13.5.7 South and Central America Influenza Antiviral Drugs Market Forecasts and Analysis - By Routes of Administration
13.5.8 South and Central America Influenza Antiviral Drugs Market Forecasts and Analysis - By End Users
13.5.9 South and Central America Influenza Antiviral Drugs Market Forecasts and Analysis - By Countries
13.5.9.1 Brazil Influenza Antiviral Drugs Market
13.5.9.1.1 Brazil Influenza Antiviral Drugs Market by Type
13.5.9.1.2 Brazil Influenza Antiviral Drugs Market by Treatment Type
13.5.9.1.3 Brazil Influenza Antiviral Drugs Market by Mechanism of Action
13.5.9.1.4 Brazil Influenza Antiviral Drugs Market by Vaccine Type
13.5.9.1.5 Brazil Influenza Antiviral Drugs Market by Routes of Administration
13.5.9.1.6 Brazil Influenza Antiviral Drugs Market by End Users
13.5.9.2 Argentina Influenza Antiviral Drugs Market
13.5.9.2.1 Argentina Influenza Antiviral Drugs Market by Type
13.5.9.2.2 Argentina Influenza Antiviral Drugs Market by Treatment Type
13.5.9.2.3 Argentina Influenza Antiviral Drugs Market by Mechanism of Action
13.5.9.2.4 Argentina Influenza Antiviral Drugs Market by Vaccine Type
13.5.9.2.5 Argentina Influenza Antiviral Drugs Market by Routes of Administration
13.5.9.2.6 Argentina Influenza Antiviral Drugs Market by End Users
13.5.9.3 Rest of South and Central America Influenza Antiviral Drugs Market
13.5.9.3.1 Rest of South and Central America Influenza Antiviral Drugs Market by Type
13.5.9.3.2 Rest of South and Central America Influenza Antiviral Drugs Market by Treatment Type
13.5.9.3.3 Rest of South and Central America Influenza Antiviral Drugs Market by Mechanism of Action
13.5.9.3.4 Rest of South and Central America Influenza Antiviral Drugs Market by Vaccine Type
13.5.9.3.5 Rest of South and Central America Influenza Antiviral Drugs Market by Routes of Administration
13.5.9.3.6 Rest of South and Central America Influenza Antiviral Drugs Market by End Users
14. INDUSTRY LANDSCAPE
14.1. MERGERS AND ACQUISITIONS
14.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
14.3. NEW PRODUCT LAUNCHES
14.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
15. INFLUENZA ANTIVIRAL DRUGS MARKET, KEY COMPANY PROFILES
15.1. SUN PHARMACEUTICAL INDUSTRIES LTD
15.1.1. Key Facts
15.1.2. Business Description
15.1.3. Products and Services
15.1.4. Financial Overview
15.1.5. SWOT Analysis
15.1.6. Key Developments
15.2. ADMA BIOLOGICS, INC
15.2.1. Key Facts
15.2.2. Business Description
15.2.3. Products and Services
15.2.4. Financial Overview
15.2.5. SWOT Analysis
15.2.6. Key Developments
15.3. SHIONOGI INC
15.3.1. Key Facts
15.3.2. Business Description
15.3.3. Products and Services
15.3.4. Financial Overview
15.3.5. SWOT Analysis
15.3.6. Key Developments
15.4. F. HOFFMANN-LA ROCHE LTD
15.4.1. Key Facts
15.4.2. Business Description
15.4.3. Products and Services
15.4.4. Financial Overview
15.4.5. SWOT Analysis
15.4.6. Key Developments
15.5. CIPLA INC
15.5.1. Key Facts
15.5.2. Business Description
15.5.3. Products and Services
15.5.4. Financial Overview
15.5.5. SWOT Analysis
15.5.6. Key Developments
15.6. GLAXOSMITHKLINE PLC
15.6.1. Key Facts
15.6.2. Business Description
15.6.3. Products and Services
15.6.4. Financial Overview
15.6.5. SWOT Analysis
15.6.6. Key Developments
15.7. TEVA PHARMACEUTICAL INDUSTRIES LTD
15.7.1. Key Facts
15.7.2. Business Description
15.7.3. Products and Services
15.7.4. Financial Overview
15.7.5. SWOT Analysis
15.7.6. Key Developments
15.8. NOVARTIS AG
15.8.1. Key Facts
15.8.2. Business Description
15.8.3. Products and Services
15.8.4. Financial Overview
15.8.5. SWOT Analysis
15.8.6. Key Developments
15.9. SANOFI
15.9.1. Key Facts
15.9.2. Business Description
15.9.3. Products and Services
15.9.4. Financial Overview
15.9.5. SWOT Analysis
15.9.6. Key Developments
15.10. ASTRAZENECA
15.10.1. Key Facts
15.10.2. Business Description
15.10.3. Products and Services
15.10.4. Financial Overview
15.10.5. SWOT Analysis
15.10.6. Key Developments
16. APPENDIX
16.1. ABOUT THE INSIGHT PARTNERS
16.2. GLOSSARY OF TERMS
The List of Companies
1. Sun Pharmaceutical Industries Ltd
2. ADMA Biologics, Inc
3. Shionogi Inc
4. F. Hoffmann-La Roche Ltd
5. Cipla Inc
6. GlaxoSmithKline Plc
7. Teva Pharmaceutical Industries Ltd
8. Novartis AG
9. Sanofi
10. AstraZeneca
1. Sun Pharmaceutical Industries Ltd
2. ADMA Biologics, Inc
3. Shionogi Inc
4. F. Hoffmann-La Roche Ltd
5. Cipla Inc
6. GlaxoSmithKline Plc
7. Teva Pharmaceutical Industries Ltd
8. Novartis AG
9. Sanofi
10. AstraZeneca
Get the Latest COVID-19 Analysis on this market
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak To Analyst
Pricing
-
$3000
-
$4550
-
$6550
-
$8550
-
Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.
Inquire for Discount